Overview

Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients

Status:
Active, not recruiting

Trial end date:
2022-07-01

Target enrollment:

Participant gender:

Summary

Patient failure to take medications as prescribed (medication non-adherence) is now identified as an important cause of kidney transplant failure. The availability of new drugs that are taken once daily may improve patient adherence compared to older drugs that had to be taken twice per day. In this study, patients will be converted to a medication schedule where all medications are taken once daily with the goal of improving patient adherence and satisfaction.

Phase:

N/A

Details

Lead Sponsor:

University of British Columbia

Collaborator:

Astellas Pharma Canada, Inc.

Treatments:

Antihypertensive Agents
Azathioprine
Cyclosporine
Cyclosporins
Mycophenolate mofetil
Mycophenolic Acid
Prednisone
Tacrolimus